For the study, researchers assessed all patients diagnosed with HCC at the Mayo Clinic from 2007-2009. Results showed hepatitis C virus (36 percent), alcohol use (29 percent) and nonalcoholic fatty liver disease (13 percent) were the most common risk factors for HCC. Research findings also demonstrated transarterial chemoembolization, surgical resection and liver transplantation were the three most common HCC treatments, and patients who were diagnosed with HCC during surveillance were more likely to undergo potentially curative treatments and yield improved survival times.
Read the study about risk factors for hepatocellular carcinoma.
Read other coverage about GI:
– Adding New Drug Boceprevir Can Help Treat Hepatitis C
– Cirrhosis and HCC Increasing Among Hepatitis C Patients
– Gastroenterologist Reflects on Growing Number of Trials Related to Bowel Prep
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
